Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Carcinoma|Breast Tumors|Malignant Neoplasm of Breast
Interventions: DRUG: Paclitaxel|DRUG: Alisertib
Sponsor: US Oncology Research
Collaborators: Millennium Pharmaceuticals, Inc.